Skip to main content

Table 1 Clinicopathological characteristics of all subjects included in this study

From: Urinary microbiome dysbiosis is associated with an inflammatory environment and perturbed fatty acids metabolism in the pathogenesis of bladder cancer

 

Before group (n = 23)

Control group (n = 9)

p-value

Age, y

64.30 ± 11.18

56.44 ± 12.89

0.12

Sex, n (%)

  

1.00

 Male

20 (86.96%)

8 (88.89%)

 

 Female

3 (13.04%)

1 (11.11%)

 

BMI, kg/m2

23.46 ± 3.36

23.81 ± 2.59

0.79

Smoking history, n (%)

  

0.02

 Smoker

17 (73.91%)

2 (22.22%)

 

 Nonsmoker

6 (26.09%)

7 (77.78%)

 

UTI history, n (%)

  

0.006

 Yes

18 (78.26%)

2 (22.22%)

 

 No

5 (21.74%)

7 (77.78%)

 

Urolithiasis, n (%)

  

1.00

 Yes

3 (13.04%)

1 (11.11%)

 

 No

20 (86.96%)

8 (88.89%)

 

Comorbidities, frequencies

  

–

 Hypertension

15

3

 

 Diabetes mellitus

3

1

 

 Cardiovascular diseases

2

0

 

 Hyperplasia prostate

4

3

 

 Others

1

1

 

TNM stage, n (%)

 

–

–

 0–I

13 (56.52%)

  

 II

3 (13.04%)

  

 III

3 (13.04%)

  

 IV

0

  

Unknown/Unclassified

4 (17.40%)

  

WHO grade, n (%)

 

–

–

 1

6 (26.09%)

  

 2

6 (26.09%)

  

 3

7 (30.43%)

  

 Unknown/Unclassified

4 (17.39%)

  

Treatment

 

–

–

 TURBT

18 (78.26%)

  

 Laparoscopic radical cystectomy

2 (8.70%)

  

 Laparoscopic partial cystectomy

3 (13.04)

  
  1. BMI: Body mass index; UTI: Urinary tract infection; TNM: Tumor Node Metastasis classification; WHO: World Health Organization; TURBT: Transurethral resection of bladder tumors. p was calculated by Student’s t-test or Fisher’s exact test